The official blog of the Lung Institute.

International Women’s Day 2015

8 Mar 2015
| Under Lung Disease | Posted by | 0 Comments
International Woman's Day 2015 Lung Institute


All around the world, International Women’s Day represents an opportunity to celebrate women all while calling for greater equality. It’s a day to congratulate women for all of their amazing achievements and milestones surpassed. It’s a day to reflect on the concerns of women around the world. It’s a day of unity.

This year, International Women’s Day is surrounded around the theme #MakeItHappen. It means that now is no longer a time for excuses. It’s time for action. It’s time for change. Whether that means acknowledging the desire for your child to have US citizenship, advocating for equal pay or ending workplace harassment, there is no better time to make change happen than now.

All change starts with awareness; so this International Women’s Day, the Lung Institute wants disease awareness to happen. These conditions often leave sufferers struggling for air. For far too long, people have assumed that men are the primary targets of chronic lung diseases like COPD. Previous research and statistics have supported the notion that lung disease is primarily a men’s disease, but new studies now show that women may actually be affected by lung disease to a greater extent.

Quick Facts about Women and Lung Disease

  1. Women are 37 percent more likely to have COPD than men.
  2. Women also account for more than half of all deaths attributed to COPD in the United States.
  3. Female smokers are nearly 13 times more likely to die from COPD compared to women who have never smoked.
  4. Females are approximately twice as likely to be diagnosed with chronic bronchitis as men.
  5. Women who present identical symptoms as men to a physician are less likely to be diagnosed with COPD; this is most likely due to the stereotype that COPD is a “man’s disease.”

Women are amazing at a great number of things. We are also great at dying from COPD. For twelve consecutive years, women have exceeded men in the number of deaths attributable to COPD. This is not okay. In order to stop the dying, we need to make a change. COPD cannot be simply seen as a “man’s disease.” The world needs to face the facts. Chronic lung diseases do not discriminate. We’ve all heard it before: early detection saves lives. By rupturing the stereotype, we can save women’s lives. Now, we just need to #MakeItHappen.

If you are suffering from the debilitating effects of a chronic lung disease, now is your chance to make a change. There is more to life than lung disease. Stem cell therapy may be able help you breathe easier and live life to the fullest. Contact the Lung Institute or call us at (800) 729-3065 to make it happen.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.